Resonance Health ROE 2024

Resonance Health Aktienanalyse

What does Resonance Health do?

Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Resonance Health's Return on Equity (ROE)

Resonance Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Resonance Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Resonance Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Resonance Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Resonance Health stock

What is the ROE (Return on Equity) of Resonance Health this year?

The ROE of Resonance Health this year is 0.02 undefined.

How has the Return on Equity (ROE) of Resonance Health developed compared to the previous year?

The ROE of Resonance Health has increased by -114.5% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Resonance Health?

A high ROE indicates that Resonance Health generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Resonance Health?

A low ROE can indicate that Resonance Health is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Resonance Health affect the company?

A change in ROE (Return on Equity) of Resonance Health can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Resonance Health?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Resonance Health?

Some factors that can influence Resonance Health's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Resonance Health pay?

Over the past 12 months, Resonance Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Resonance Health is expected to pay a dividend of 0 AUD.

What is the dividend yield of Resonance Health?

The current dividend yield of Resonance Health is .

When does Resonance Health pay dividends?

Resonance Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Resonance Health?

Resonance Health paid dividends every year for the past 0 years.

What is the dividend of Resonance Health?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Resonance Health located?

Resonance Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Resonance Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Resonance Health from 11/4/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Resonance Health pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Resonance Health in the year 2023?

In the year 2023, Resonance Health distributed 0 AUD as dividends.

In which currency does Resonance Health pay out the dividend?

The dividends of Resonance Health are distributed in AUD.